🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This phase I/II trial tests the side effects and best dose of abemaciclib w...
Status
Recruiting
Location
UT MD Anderson Cancer Center
Start Date
2026-03-18
Trial ID
NCT06498648
Treatments Being Tested
This phase I/II trial studies the safety, side effects, and best dose of de...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-09-23
Trial ID
NCT06928662
Post-operative care following liver transplantation is characterized by a h...
Status
Completed
Location
Multiple Locations
Start Date
2016-01-08
Trial ID
NCT04302246
Treatments Being Tested
This is a study in adults with severe breathing problems because of COVID-1...
Status
Completed
Location
LKH Klagenfurt am Woerthersee
Start Date
2020-12-16
Trial ID
NCT04640194
Treatments Being Tested
DOACs are increasingly used since 8 years. Standard coagulation tests (Prot...
Status
Unknown
Location
Clincial Research Serivces
Start Date
2022-07-01
Trial ID
NCT05491460
Treatments Being Tested
RATIONALE: Tretinoin may help cells that are involved in the body's immune ...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2004-08
Trial ID
NCT00100906
This phase II, open-label, single-arm, study investigates the clinical bene...
Status
Recruiting
Location
Ichilov-Sourasky Medical Center
Start Date
2022-09-01
Trial ID
NCT07646171
The goal of this clinical trial is to learn if adding alpha interferon to s...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT07671495
This phase III ALCHEMIST treatment trial tests the addition of pembrolizuma...
Status
Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2020-06-16
Trial ID
NCT04267848